Company & Sponsor Intelligence
Northwell Health
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials5
Recruiting1
Completed4
Countries1
Therapeutic footprint
adhdalzheimersepilepsyparkinsons
Indexed studies
NCT04721691Efficacy of Epidiolex in Patients With Electrical Status Epilepticus of Sleep (ESES).
epilepsy · United StatesPHASE1
epilepsy · United StatesPHASE1
NCT04228172Genotypic Influences on Network Progression in Parkinson's Disease
parkinsons · United StatesACTIVE_NOT_RECRUITING
parkinsons · United StatesACTIVE_NOT_RECRUITING
NCT06801912A BCT Intervention for an Hourly Activity Habit Among Caregivers for Persons With AD/ADRD
alzheimers · United StatesNA
alzheimers · United StatesNA
NCT06803797BCT Intervention For Walking Habit Among Caregivers of People With AD/ADRD
alzheimers · United StatesNA
alzheimers · United StatesNA
NCT05588505Cognitive-Behavioral Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in College Students - Study 1
adhd · United StatesNA
adhd · United StatesNA
Intelligence layer updated: 2026-10-14 06:11:28.884102+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →